factual
Competitor safety data appears worse on the same target
Early data from competitor drugs on the same target show a large safety gap versus Argenx's drug, which Julia argues is a key differentiator.
factualpending
Speaker
JuliaEvidence Quote
“there is a massive difference. More importantly, it's on the safety”
Created: 11/17/2026, 3:39:21 AM
Your notes
Loading notes...